✦ LIBER ✦

New molecules in the ovarian cancer therapy

✍ Scribed by Michele Maffia; Daniela Toraldo; Andrea Tinelli; Angelo Santino; Daniela Vergara

Book ID: 108105455
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 73 KB
Volume: 22
Category: Article
ISSN: 0958-1669
DOI: 10.1016/j.copbio.2011.05.050

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Promising new therapies in the treatment

Promising new therapies in the treatment of advanced ovarian cancer

✍ Carolyn D. Runowicz; Abbie L Fields; Gary L. Goldberg 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 599 KB

Advanced stage ovarian cancer is the most lethal gynecologic cancer. Despite initial response rates of 60-80'/0 with platinum-based chemotherapy, more than 75% of women with this malignancy die of complications associated with this disease. There is a pressing need to find new chemotherapeutic agent

Hormonal therapy in ovarian cancer

✍ H. ZHENG; J.J. KAVANAGH; W. HU; Q. LIAO; S. FU 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

Trial design for testing new therapies i

Trial design for testing new therapies in ovarian cancer

✍ E.A. EISENHAUER 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Novel antiangiogenic therapies in ovaria

Novel antiangiogenic therapies in ovarian cancer

✍ Stuckey, Ashley; Dizon, Don S 📂 Article 📅 2012 🏛 Future Medicine 🌐 English ⚖ 425 KB

Hormone replacement therapy and ovarian

Hormone replacement therapy and ovarian cancer risk – any news?

✍ TOMAS RIMAN 📂 Article 📅 2007 🏛 Informa plc 🌐 English ⚖ 48 KB

The integration of new therapies and rad

The integration of new therapies and radiation in the management of ovarian cancer

✍ Stanley E. Order; Neil Rosenshein; Jerry L. Klein; Steve Leibel; Jose Pino Y Tor 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 602 KB